Agiliti, Inc. (NYSE:AGTI) EVP Sells $47,037.40 in Stock

Agiliti, Inc. (NYSE:AGTI) EVP Lee M. Neumann sold 4,685 shares of Agiliti stock in a transaction on Tuesday, April 9th. The stock was sold at an average price of $10.04, for a total value of $47,037.40. Following the sale, the executive vice president now owns 29,929 shares in the company, valued at $300,487.16. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.

Agiliti Trading Down 0.2 %

Shares of AGTI opened at $10.02 on Friday. The business’s 50-day moving average price is $9.15 and its 200-day moving average price is $7.71. The company has a quick ratio of 1.34, a current ratio of 1.72 and a debt-to-equity ratio of 1.13. The stock has a market cap of $1.36 billion, a PE ratio of -71.57 and a beta of 1.95. Agiliti, Inc. has a twelve month low of $5.07 and a twelve month high of $18.61.

Agiliti (NYSE:AGTI) last announced its earnings results on Tuesday, March 5th. The company reported $0.11 earnings per share for the quarter, topping analysts’ consensus estimates of $0.10 by $0.01. The business had revenue of $291.99 million for the quarter, compared to analyst estimates of $291.99 million. Agiliti had a positive return on equity of 6.47% and a negative net margin of 1.65%. On average, equities analysts forecast that Agiliti, Inc. will post 0.49 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. Wells Fargo & Company MN lifted its stake in Agiliti by 180.8% in the fourth quarter. Wells Fargo & Company MN now owns 1,536 shares of the company’s stock worth $25,000 after acquiring an additional 989 shares during the period. Goldman Sachs Group Inc. lifted its position in shares of Agiliti by 2.4% in the 1st quarter. Goldman Sachs Group Inc. now owns 49,865 shares of the company’s stock worth $1,052,000 after purchasing an additional 1,150 shares during the period. American International Group Inc. boosted its stake in shares of Agiliti by 10.1% during the 2nd quarter. American International Group Inc. now owns 12,845 shares of the company’s stock valued at $263,000 after purchasing an additional 1,177 shares in the last quarter. Macquarie Group Ltd. purchased a new position in shares of Agiliti during the second quarter valued at about $28,000. Finally, GAMMA Investing LLC increased its position in shares of Agiliti by 144.1% during the first quarter. GAMMA Investing LLC now owns 2,688 shares of the company’s stock valued at $27,000 after buying an additional 1,587 shares during the period. 99.12% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

AGTI has been the subject of a number of research analyst reports. TheStreet upgraded shares of Agiliti from a “d” rating to a “c-” rating in a report on Tuesday, March 5th. KeyCorp initiated coverage on shares of Agiliti in a report on Tuesday, February 6th. They issued a “sector weight” rating on the stock. Craig Hallum assumed coverage on Agiliti in a report on Thursday, January 4th. They set a “buy” rating and a $23.00 price objective for the company. UBS Group restated a “neutral” rating and issued a $10.00 target price on shares of Agiliti in a research note on Thursday, March 7th. Finally, Raymond James reiterated a “market perform” rating on shares of Agiliti in a research note on Tuesday, March 26th. Two equities research analysts have rated the stock with a sell rating, four have given a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $14.17.

Agiliti Company Profile

Agiliti, Inc, together with its subsidiaries, provides healthcare technology management and service solutions to the healthcare industry in the United States. The company offers onsite managed services that are comprehensive programs for the management, reprocessing, and logistics of medical equipment at individual facilities and integrated delivery networks to monitor and adjust equipment quantities and availability to address fluctuations in patient census and acuity.